Fiche du document
1 octobre 2012
- handle: 10670/1.uni4kf
Ce document est lié à :
10.4067/S0718-27242012000300005
info:eu-repo/semantics/openAccess
Mots-clés
production biopharmaceuticals specialty drugs strategic medication patents technological forecastingSujets proches
Knowledge discovery in data Factual data analysis KDD (Information retrieval) Mining, Data Knowledge discovery in databases Algorithmic knowledge discovery Granulocyte-colony stimulating factor G-CSF (Colony-stimulating factor) Technology--Forecasting Growth hormone Somatotrophic hormone Somatotropic hormone Somatropin Pituitary growth hormone Somatotrophin Window displays Display windows Window dressing Papers Products, Manufactured Manufactured goods Products Manufactured products Interest and usury Industrial production Industry Wellness Personal health Medications Medicaments Prescription drugs Medicines (Drugs) Pharmaceuticals Medicine (Drugs) Use of Biography--HealthCiter ce document
Luciana da Silva Madeira et al., « Prospects and Trends in the Brazilian Market for Biologically Sourced Products », Journal of Technology Management & Innovation, ID : 10670/1.uni4kf
Métriques
Partage / Export
Résumé
The aim of this paper was to select the most interesting Brazilian biopharmaceuticals, with the best market opportunity for production. The biopharmaceuticals filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII were selected because they are not produced in Brazil and thus could increase the technological capacity of domestic production. The use of a data mining tool facilitated the results achieved here, using the patents deposited in several banks worldwide as the source information. The prospects and trends of producing biopharmaceuticals in Brazil are of great interest to the country to establish a competitive industry and reduce the vulnerability of the National Health System, such as display windows of opportunity, showing the possibility of moving towards the production of biopharmaceuticals.